Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
Sézary syndrome (SS), an aggressive form of erythrodermic pruritic cutaneous T cell lymphoma (CTCL), from an immunological perspective characterized by increased Th2 cytokine levels, elevated serum IgE and impaired cellular immunity. Not only the clinical appearance but also the hallmark immunologic...
Main Authors: | Ieva Saulite, Wolfram Hoetzenecker, Stephan Weidinger, Antonio Cozzio, Emmanuella Guenova, Ulrike Wehkamp |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2016/9717530 |
Similar Items
-
Pseudolymphomatous Reaction to Red Tattoo Pigment
by: Ieva Saulite, et al.
Published: (2018-06-01) -
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
by: Ieva Saulite, et al.
Published: (2020-01-01) -
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome
by: Christoph Iselin, et al.
Published: (2021-01-01) -
Immunological Aspects of Skin Aging in Atopic Dermatitis
by: Georgeta St. Bocheva, et al.
Published: (2021-05-01) -
Toxic epidermal necrolysis [version 1; referees: 3 approved]
by: Wolfram Hoetzenecker, et al.
Published: (2016-05-01)